Vimarsana
Biggest News Aggregation in the World

Benjamin Chong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Chong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Chong Today - Breaking & Trending Today

Skin Issues Can Be First Sign of Rheumatological Illnesses - Vimarsana News

Skin Issues Can Be First Sign of Rheumatological Illnesses

TUESDAY, April 25, 2023 (HealthDay News) -- Skin conditions may be the first sign that a person has a rheumatic disease that will also affect the joints, muscles or ligaments.

Skin conditions may indicate underlying rheumatic disease - Vimarsana News

Skin conditions may indicate underlying rheumatic disease

Skin conditions may be the first sign that a person has a rheumatic disease that will also affect the joints, muscles or ligaments.

Source: upi.com
Integrating Renewable-Energy Resources and Hybrid Energy-Storage Systems via Microgrids - Vimarsana News

Integrating Renewable-Energy Resources and Hybrid Energy-Storage Systems via Microgrids

The intermittent and irregular power supply of renewable-energy resources necessitates the development of suitable energy-storage systems. In an Asia Sustainable Development Goals Group project, researchers in the Worldwide Universities Network have integrated wind and solar farms with a hybrid energy-storage system based on supercapacitor and flow battery and employed DC microgrids with control systems. While…

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus - Vimarsana News

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, randomized, placebo-controlled trial to evaluate its development-stage medicine daxdilimab, a potentially

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus | Antibodies - Vimarsana News

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus | Antibodies

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus